The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (5) , 2195-2197
- https://doi.org/10.1016/s0041-1345(98)00588-0
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.The Journal of Immunology, 1997
- SDZ RAD, A NEW RAPAMYCIN DERIVATIVETransplantation, 1997
- SDZ RAD, A NEW RAPAMYCIN DERIVATIVETransplantation, 1997
- IN VIVO ANTI-CD3-DRIVEN CELL ACTIVATIONTransplantation, 1996
- CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin.Journal of Biological Chemistry, 1994
- Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinaseNature, 1992
- An improved colorimetric assay for interleukin 2Journal of Immunological Methods, 1986